| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | US7112418 Ion channel |
| 09/26/2006 | US7112414 Masp-2, a complement-fixing enzyme, and uses for it |
| 09/26/2006 | US7112337 Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic |
| 09/26/2006 | US7112331 Vaccines against varicella zoster virus gene 63 product |
| 09/26/2006 | US7112324 CD 19×CD3 specific polypeptides and uses thereof |
| 09/26/2006 | US7112321 Amyothropic lateral sclerosis; gene therapy |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/24/2006 | CA2539281A1 Methods for the treatment of insulin resistance and disease states characterized by insulin resistance |
| 09/21/2006 | WO2006099574A2 Cockroach allergen gene expression and delivery systems and uses |
| 09/21/2006 | WO2006099561A1 Immunogenic compositions comprising lawsonia intracellularis |
| 09/21/2006 | WO2006099495A2 Method for preventing or treating pain in a mammal |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006099021A2 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 09/21/2006 | WO2006098488A1 Method of ameliorating symptom caused by mood disturbance |
| 09/21/2006 | WO2006098314A1 Novel sugar uptake activator and method for screening the same |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006098074A1 Apoptosis inducing agent for prostate carcinoma cell |
| 09/21/2006 | WO2006097945A2 A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure |
| 09/21/2006 | WO2006097854A1 Heterodimeric meganucleases and use thereof |
| 09/21/2006 | WO2006070023A3 Method for reversing multiple resistance in animal cells |
| 09/21/2006 | WO2006055947A3 Methods of regulating angiogenesis through stabilization of pedf |
| 09/21/2006 | WO2006031267A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 09/21/2006 | WO2006012393A3 Addition of transgenes into adenoviral vectors |
| 09/21/2006 | WO2006007372A3 Drug delivery product and methods |
| 09/21/2006 | WO2005100383A8 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 09/21/2006 | US20060212959 Transposase and method of gene modification |
| 09/21/2006 | US20060212958 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids |
| 09/21/2006 | US20060212950 Inducible small rna expression constructs for targeted gene silencing |
| 09/21/2006 | US20060211647 Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes; for treatment of mitochondrial diseases |
| 09/21/2006 | US20060211646 Formulations with anti-tumour action |
| 09/21/2006 | US20060211645 Modulation of neurodegenerative diseases |
| 09/21/2006 | US20060211644 Immunostimulatory oligonucleotides |
| 09/21/2006 | US20060211643 Polycations capable of forming complexes with nucleic acids |
| 09/21/2006 | US20060211642 Controlling gene expression; enzyme inhibitors |
| 09/21/2006 | US20060211641 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/21/2006 | US20060211640 Antisense modulation of farnesoid X receptor expression |
| 09/21/2006 | US20060211639 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 09/21/2006 | US20060211638 Exon 1 ss of pdgf alpha gene and utilization thereof |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211615 Surfactant peptide nanostructures, and uses thereof |
| 09/21/2006 | US20060211116 Transposase and method of gene modification |
| 09/21/2006 | US20060211115 Methods of generating chimeric adenoviruses and uses for such chimeric aden oviruses |
| 09/21/2006 | US20060211114 Modulation of hedgehog-mediated signaling pathway |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211042 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 09/21/2006 | US20060211033 Novel gene |
| 09/21/2006 | US20060211025 Molecular signatures of commonly fatal carcinomas |
| 09/21/2006 | US20060211020 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 09/21/2006 | US20060211015 detecting a difference between the levels of an expression product of a cancer associated (CA) gene in a cell in the presence and absence of an anticancer drug candidate; for carcinomas, especially lymphoma carcinomas |
| 09/21/2006 | US20060210977 Transposon-based vectors and methods of nucleic acid integration |
| 09/21/2006 | US20060210975 Secreted and cytoplasmic tumor endothelial markers |
| 09/21/2006 | US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes |
| 09/21/2006 | US20060210965 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 09/21/2006 | US20060210591 Immunization of an individual against carcinomas and the preliminary stages thereof |
| 09/21/2006 | US20060210588 Hiv-peptide-carrier-conjugates |
| 09/21/2006 | US20060210576 Method for treating or preventing metastasis of colorectal cancers |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210564 Novel diabody-type bispecific antibody |
| 09/21/2006 | US20060210544 Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| 09/21/2006 | US20060210541 Methods for treating and preventing vascular disease |
| 09/21/2006 | US20060210540 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/21/2006 | US20060210539 Activating expression of an endogenous Pigment Epithelium Derived Factor gene in one or more cells of an organism; ocular neovascularization in an organism |
| 09/21/2006 | US20060210538 Use of apotosis inhibiting compounds in degenerative neurological disorders |
| 09/21/2006 | US20060210537 Theileria parva DNA vaccines |
| 09/21/2006 | US20060210536 Methods and compositions for inhibiting stat signaling pathways |
| 09/21/2006 | US20060210535 Means for regulating the expression of human isoforms of ant |
| 09/21/2006 | DE102006006808A1 Nanobiotechnologische Vorrichtung für Anatomiestrukturnachbildungen Nanobiotechnological apparatus for anatomy structure reproductions |
| 09/21/2006 | CA2600877A1 Immunogenic compositions comprising lawsonia intracellularis |
| 09/21/2006 | CA2600440A1 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 09/21/2006 | CA2581402A1 Novel activating agent of glucose uptake and a screening method therefor |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1702984A2 A method for detecting prostate cancer |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702927A1 Attenuated microorganisms for the treatment of infection |
| 09/20/2006 | EP1702620A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 09/20/2006 | EP1702213A1 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2 |
| 09/20/2006 | EP1702072A1 Genetic therapy and genetic modification using neocentromeric minichromosomes |
| 09/20/2006 | EP1701737A2 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 09/20/2006 | EP1701711A1 Nanoparticles for delivery of a pharmacologically active agent |
| 09/20/2006 | EP1631672B1 Circular expression construct for gene therapeutic applications |
| 09/20/2006 | EP1549755A4 Spliceosome mediated rna trans-splicing in stem cells |
| 09/20/2006 | EP1432792B1 Histone deacetylase 9 |
| 09/20/2006 | EP1280897B1 Regulation of nf-at interacting protein nip 45 variant |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1037611A4 Biodegradable mixed polymeric micelles for gene delivery |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | CN1836042A Conserved HBV and HCV sequences useful for gene silencing |
| 09/20/2006 | CN1836037A Novel modified corin molecules having substitute activation sequences and uses thereof |
| 09/20/2006 | CN1835971A Improved secretion of neublastin |
| 09/20/2006 | CN1835968A Compositions and methods for increasing bone mineralization |
| 09/20/2006 | CN1834255A Method of fast increasing glandular related virus mediating gene in expression of inside of retina cell |
| 09/20/2006 | CN1834254A Carrier PCD-VEGF able to stable express VEGF shRNA |
| 09/20/2006 | CN1834242A Use of artificial proliferative inhibiting gene-adenovirus expression carrier |
| 09/20/2006 | CN1276083C Altering gene expression with ssDNA produced in vivo |
| 09/19/2006 | US7109397 Comprises nucleotide sequences coding hypersensitive response elicitor protein (HREP) for conferring improved ripening, flowering, longevity and disease, stress and dessication resistance to plants; biological pest control |
| 09/19/2006 | US7109322 Process for the depletion or removal of endotoxins |